Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Company n/r · Phase 3 · Completed · Enrollment 159

NCT07820111

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
obese , non diabetic ,recieve dulaglutiden/rn/rn/rn/rn/r
obese , non diabetic ,receive SEMAGLUTIDEn/rn/rn/rn/rn/r
obese , non diabetic ,receive TIRAZEPETIDEn/rn/rn/rn/rn/r
obese , diabetic ,recieve dulaglutiden/rn/rn/rn/rn/r
obese , diabetic ,receive SEMAGLUTIDEn/rn/rn/rn/rn/r
obese , diabetic ,receive TIRAZEPETIDEn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.